Press releaseACCESS Newswire
Hypha Labs
FUNI · OTC
$0.0043+$0.0001 (+2.38%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseACCESS Newswire
Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion
- Press releaseACCESS Newswire
Trump Psychedelic Executive Order Accelerates Industry Growth
- Press releaseACCESS Newswire
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
- Press releaseACCESS Newswire
Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing
- Press releaseACCESS Newswire
Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator
- Press releaseACCESS Newswire
Hypha Labs Provides Shareholder Update
- Press releaseACCESS Newswire
Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator
- Press releaseACCESS Newswire
Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator
- Press releaseGlobe Newswire
Emerging Markets Report: A Milestone for Mycelium
- Press releaseACCESS Newswire
Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade
- Press releaseACCESS Newswire
New Mexico Governor Signs Bill Allowing for Psilocybin Use
- Press releaseACCESS Newswire
Hypha Laboratories Retains Stockhouse for International Awareness Campaign
- Press releaseGlobe Newswire
Emerging Markets Report: Breakthroughs & Bureaucracy
- Press releaseACCESS Newswire
Hypha Laboratories Reports Significant Breakthrough for MicroPearls(TM) Yields
- Press releaseACCESS Newswire
Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms
- Press releaseACCESSWIRE
Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes
- Press releaseGlobe Newswire
Emerging Markets Report: A Mushroom Monster in the Making
- Press releaseACCESSWIRE
Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown
- Press releaseACCESSWIRE
Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production
- Press releaseACCESSWIRE
Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production
- Press releaseACCESSWIRE
Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services
- Press releaseACCESSWIRE
Hypha Labs, Inc. Releases Investor Presentation
- Press releaseACCESSWIRE
Hypha Labs, Inc. Uplists to the OTCQB
- Press releaseACCESSWIRE
Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.